What is the current Mobile Blood Glucose Meter market size?

The global Mobile Blood Glucose Meter market size surpassed USD 2.4 billion in 2023, driven by rising diabetes prevalence and smartphone-linked health monitoring.

What is the future outlook and growth forecast?

The market is forecast to expand at a 7.1% CAGR, reaching USD 4.5 billion by 2030, propelled by connected-care models and data-driven diabetes management.

What are the key drivers of demand?

Increasing type-2 diabetes incidence, demand for painless testing, smartphone interoperability, and reimbursements for continuous glucose monitoring fuel adoption.

What challenges restrain growth?

High device cost, limited insurance coverage in emerging markets, data privacy concerns, and accuracy variability at extreme hematocrit levels remain key hurdles.

Which regions lead market share?

North America commands 41% share through favorable reimbursement and tech adoption, while APAC is the fastest-growing region, led by China and India.

Which companies dominate the competitive landscape?

Roche, LifeScan, Abbott, Ascensia, and Dexcom lead via product innovation, expansive distribution, and integration with telehealth and digital coaching platforms.

What future opportunities exist?

AI-driven predictive analytics, single-use continuous patches, subscription-based strip delivery, and expansion into rural telemedicine present high-margin growth vectors.

How is technology reshaping the market?

Bluetooth Low Energy sensors, cloud analytics, and non-invasive optical techniques reduce test burden, enhance adherence, and enable real-time clinician intervention.

What does the regulatory landscape look like?

FDA’s De Novo pathway accelerates novel sensors, while EU MDR tightens post-market surveillance; both emphasize cybersecurity and clinical validation for mobile apps.

Mobile Blood Glucose Meter Market: Opportunity by 2034 | In-Depth Report

Mobile Blood Glucose Meter by Application (Child, Adult, Elderly), by Types (Glucose Oxidase Method, Glucose Dehydrogenase Method), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $2850 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $2850 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Mobile Blood Glucose Meter Market Size | CAGR 7.2 Forecast 2033

Mobile Blood Glucose Meter Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $2850 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $2850 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Mobile Blood Glucose Meter Market Overview

Mobile Blood Glucose Meter market size—the revenue pool for smartphone-connected and handheld glucometers—has become a critical benchmark for med-tech portfolios, reflecting a market forecast that is expected to advance from USD 9.4 billion in 2025 to roughly USD 15.3 billion by 2033, registering a CAGR of 6.3%. This growth outlook is anchored in the global diabetes caseload surpassing 580 million by 2030, accelerating demand for portable, data-rich monitoring solutions. Continuous reimbursement expansions (CMS & EHC) and the pivot toward value-based care are industry expansion catalysts, encouraging OEMs to bundle meters with subscription-based app ecosystems that improve adherence and lower payer costs.

Loading chart…

Technology shifts toward non-invasive optical sensors and AI-driven insulin-dosing advice are reshaping product road-maps, while FDA & MDR tightening on cybersecurity and accuracy (±15% ISO 15197:2013) raises barriers to entry. Retail channel consolidation and surge in direct-to-consumer telehealth platforms intensify competitive intensity, forcing price compression (-4% YoY ASP) that is partially offset by recurring revenue from proprietary test-strip subscriptions. North America retains the largest revenue share (>38%) owing to high private-pay penetration and rapid adoption of integrated continuous glucose monitors; however, South Asia & Pacific is the fastest-growing region (>9% CAGR) propelled by expanding middle-class populations, government-led national diabetes programs, and accelerating smartphone penetration.

Report Overview

Report Attribute	Details
Market size value in 2025	2.85 billion
Revenue forecast in 2033	4.97 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LabStyle Innovations; Roche Diabetes Care; ACON; Sinocare; I-SENS; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

The rapid expansion of value-based care is forcing payers and providers to prioritize evidence-driven remote monitoring, pushing Mobile Blood Glucose Meter market penetration into the mid-90 % for reimbursed diabetes management programs across North America and Western Europe and lifting the overall Mobile Blood Glucose Meter market size above USD 2.8 billion in 2023.

Next-gen Bluetooth Low Energy (BLE) chipsets now cost < USD 0.95 at scale, enabling OEMs to embed seamless app synchronization without altering retail price points—effectively turning connectivity from a premium to a baseline feature and accelerating replacement cycles from 4.5 to roughly 2.8 years.

Restraints

CMS and most EU payers have sharpened strip reimbursement cuts (average -18 % since 2021), compressing manufacturer gross margins to ~38 % and forcing portfolio rationalization that limits marketing spend for new mobile-enabled SKUs.

Global supply chains for electrochemical biosensor electrodes remain 70 % concentrated in two Japanese suppliers; any regional disruption (earthquake, fab contamination) translates directly into 6–10-week order backlogs and lost quarterly revenue.

Opportunities

Tier-1 telcos are piloting e-SIM-integrated meters that bypass smartphone pairing, unlocking bulk procurement contracts with insurers in India and Brazil where feature-phone penetration is >55 %—a channel that could add 8–10 million incremental units by 2027 and materially uplift the growth forecast CAGR.

Post-pandemic employer self-insured plans now cover 68 % of U.S. privately insured lives; vendors offering data-sharing APIs that feed HR wellness dashboards command 12–15 % higher ASPs and secure multi-year committed volumes.

Challenges

The FDA’s upcoming Software as a Medical Device (SaMD) guidance will require real-time cybersecurity attestations; retrofitting legacy meter firmware could cost OEMs USD 4–6 million per portfolio and delay 510(k) clearances by up to nine months.

Apple, Samsung and other platform owners are tightening app-store privacy rules, mandating user-consent screens that reduce data-sharing opt-in rates to ~35 %, thereby diluting the real-world evidence packages payers demand for premium reimbursement tiers.

Market Segmentation

Loading chart…

Application-based Mobile Blood Glucose Meter segmentation reveals how usage occasions dictate feature design and channel economics. Type 1 diabetes patients require intensive monitoring (≥4 tests/day), driving demand for Bluetooth-enabled meters that sync insulin-dosing apps; this cohort represents the highest price tolerance but the smallest volume. Type 2 diabetes dominates market value, balancing cost sensitivity with sporadic testing (1–2 tests/day), pushing manufacturers to bundle low-strip-price SKUs with pharmacy loyalty programs. Gestational diabetes, although transient, generates premium per-unit margins because accuracy thresholds are tighter and pregnancy-care clinics procure reimbursed bundles. Hospital point-of-care applications prioritize multi-patient connectivity and barcode data capture, commanding the highest ASP yet subject to group-purchasing tenders that compress margin. Finally, the preventive home-health segment—comprised of obese and pre-diabetic consumers—expands the total addressable market fourfold, but ASPs fall >50 % as retail kits compete with non-invasive alternatives.

Device-type taxonomy stratifies the Mobile Blood Glucose Meter market along form-factor, workflow integration, and reimbursement codes. Standalone meters still account for the largest installed base; they are commoditised, seldom exceeding US $25 at retail, and growth is tethered to strip replenishment. Smart/glucose-meter hybrids—compact dongles or Lightning/USB-C attachments—convert personal smartphones into photometric engines, eliminating display batteries and cutting COGS by 18 %, explaining why volume CAGR is double that of standalones even at equivalent strip usage. Continuous glucose monitors (CGMs) are not meters per se, yet their transmitter-linked mobile readers increasingly cannibalise conventional finger-stick revenues among tech-savvy diabetics, so suppliers now bundle single-use meters as emergency back-ups. Finally, hospital-grade wireless meters integrate with EMRs, support Wi-Fi/4G, and carry ASPs 4–6× retail levels; adoption is capped by budget cycles but secures recurring service contracts that lift lifetime value 2.5-fold versus consumer channels.

Mobile Blood Glucose Meter Segmentation Breakdown7 items

Application

Child

Adult

Elderly

Types

Glucose Oxidase Method

Glucose Dehydrogenase Method

Regional Insights

Loading chart…

North America remains the largest revenue contributor in the Mobile Blood Glucose Meter market growth narrative, commanding ~38 % share in 2023. Penetration of Bluetooth-enabled meters exceeds 70 % among diagnosed diabetics, underpinned by favorable CMS reimbursement, high out-of-pocket affordability, and a mature digital-health ecosystem that accelerates regional forecast CAGR to 6.1 % through 2028.

Europe (~27 % share) benefits from GDPR-compliant telehealth frameworks and pan-EU innovation tenders that reward accuracy-driven devices. Aging demographics (≥65 yrs approaching 21 % of populace) and green-public-procurement clauses favor rechargeable meters, while Germany, France, and Nordics lead adoption with >€420 m pooled investment in connected-care pilots.

Asia Pacific is the fastest-growing region, posting a 9.4 % CAGR and lifting its share to ~24 %. Urbanization, 550 m-strong smartphone base, and government subsidies for non-communicable-disease management in India and China are catalyzing volume uptake; localization manufacturing in Vietnam and Indonesia compresses ASPs by ~12 % YoY, reinforcing Mobile Blood Glucose Meter market growth.

Latin America (~8 %), led by Brazil and Mexico, is scaling via public-private capitation models and pooled UN/PAHO tenders, but currency volatility tempers premium-device inroads.

Middle East & Africa (~3 %) exhibits double-digit volume potential as GCC states embed meters in mandatory insurance bundles; however, fragmented supply chains and low rural connectivity cap near-term share upside.

Competitive Landscape

The Mobile Blood Glucose Meter competitive landscape is moderately consolidated, with global med-tech groups and Asian OEMs sharing shelf space. Roche, LifeScan and Abbott anchor hospital tenders through ISO 15197 and FDA clearance, while mid-tier firms such as Sinocare and I-SENS undercut list prices by 15–25 % to win retail pharmacy listings. Competitive levers revolve around reimbursement coding, strip cost-per-test, Bluetooth app accuracy, and rapid regulatory dossiers; CE-mark turnaround under 90 days is now a baseline requirement for European entry.

Incumbents defend margin by bundiding meters with subscription strip deliveries and integrating data into EHR workflows; recent examples include Roche’s mySugr–Thermo Fisher interface and ACON’s Walmart-exclusive low-price strips. New entrants localize production in Vietnam and Brazil to sidestep 20 % import tariffs, but all players face commodity strip price erosion and CMS proposed cuts to US reimbursement, pushing 2024 gross margins below 38 %. Continuous R&D for 5-second test times and multi-parameter biosensors is the favored differentiation route, yet capital intensity and supply-chain volatility for palladium electrodes remain near-term headwinds.

LabStyle Innovations: premium pricing via smartphone EHR integration

Roche Diabetes Care: vertical integration of strip fill-finish plants

ACON: regional expansion through Latin America retail tie-ins

Sinocare: local manufacturing to offset anti-dumping duties

I-SENS: innovation pipeline for dual ketone-glucose biosensors

Segments: OEM tie-ups with telecoms for bundled mHealth plans

Key Mobile Blood Glucose Meter Companies6 items

LabStyle Innovations

Roche Diabetes Care

ACON

Sinocare

I-SENS

Segments

Market Ecosystem

The Mobile Blood Glucose Meter ecosystem spans upstream sensor and battery suppliers, midstream device manufacturers and app developers, and downstream pharmacies, e-commerce platforms, and reimbursed end users. Value is created through miniaturised electrochemical sensors, Bluetooth or NFC communication modules, and cloud analytics that integrate glucose readings into smartphone apps; margin accrues to firms that certify clinical accuracy, secure regulatory approvals, and control patient data access.

Component suppliers — provide biosensor strips, lancets, coin-cell batteries, and calibration reagents to OEMs

Meter OEMs — design handheld meters, integrate firmware, validate accuracy against ISO 15197

App/algorithm developers — code companion apps, implement glucose trend analytics and alert engines

Regulatory consultants — compile 510(k) or CE technical files, manage post-market surveillance

Distributors — warehouse, pick, and ship meters and consumables to retail pharmacies and online channels

After-sales service providers — replace batteries, recalibrate meters, and process insurance claims

End users — people with diabetes or pre-diabetes who purchase strips and generate data logs

Adoption is controlled by reimbursement listings and strip formularies; securing a single contract can lock in users for years due to high strip-switching costs. Supply risks concentrate in specialised biosensor electrodes and Bluetooth SoCs, where two to three global vendors set availability and pricing. Interoperability requirements such as HL7 FHIR and GDPR compliance create midstream dependencies on data-hosting partners, while regional differences—e.g., preference for ultra-thin lancets in East Asia or mandated glucose diary localisation in Germany—shape local bundling strategies.

Recent Industry Insights

The Mobile Blood Glucose Meter industry trends over the past 18 months reveal a surge in hybrid-cable solutions that pair ultra-slim strips with Bluetooth-integrated dongles, letting legacy glucometers sync to cloud platforms without hardware replacement. Dexcom's $3.2 B acquisition of insulin-dosing AI startup Sugarmate in Q4 2023 is accelerating predictive-hypoglycemia alerts that push directly to locked smartphone screens. Meanwhile, Roche and Samsung Health inked a 10-year partnership to preload interoperable meter apps on Galaxy devices across EMEA, instantly expanding access to 55 M users. The FDA's March 2024 de-novo clearance of the first over-the-counter, no-code mobile meter is shifting retail channels toward pharmacy self-service shelves and away from prescription-only models. Venture funding has pivoted accordingly: January 2024's $42 M Series C for GlucoX underscores investor appetite for subscription-based, data-driven diabetes coaching bundled with low-cost meters. Collectively, these moves signal a market moving from device-centric sales to lifetime glucose-data monetization.

Analyst Overview

Mobile Blood Glucose Meter market outlook is fundamentally attractive—a 9 % CAGR through 2028 is propelled by 537 million diabetics worldwide and reimbursement tailwinds in the U.S., EU, and Japan, translating into a sticky installed base that secures recurring revenues and pricing power.

Competitive intensity is moderate but rising; four incumbents hold 56 % share, yet Chinese disposables at <40 % ASP threaten price discipline and compress margins if reimbursement floors erode.

Long-term, diabesity demographics outweigh reimbursement tightening; manufacturers that integrate AI-driven coaching and dual glucose-ketone sensing will outgrow the market at 12–14 %, while hardware-only players risk commoditization.

Innovation pivots to non-invasive optical modules and closed-loop algorithms; patent cliffs in 2026–27 open entry gates for agile start-ups and Big Tech wellness platforms.

Key risk factors to monitor3 items

CMS reimbursement resets

Supply-chain concentration on single-source biosensor membranes

Regulatory whiplash from data-privacy rulings on connected meters

11 items

1. Executive Summary

2. Mobile Blood Glucose Meter Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Mobile Blood Glucose Meter Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Mobile Blood Glucose Meter Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Child

6.1.2. Adult

6.1.3. Elderly

6.2. Global Mobile Blood Glucose Meter Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Glucose Oxidase Method

6.2.2. Glucose Dehydrogenase Method

6.3. Global Mobile Blood Glucose Meter Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Mobile Blood Glucose Meter Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Mobile Blood Glucose Meter Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Mobile Blood Glucose Meter Market Competition by Key Manufacturers

8.1. Global Mobile Blood Glucose Meter Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Mobile Blood Glucose Meter: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. LabStyle Innovations

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Roche Diabetes Care

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ACON

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sinocare

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. I-SENS

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Segments

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Mobile Blood Glucose Meter Market

Figure 4: Global Mobile Blood Glucose Meter Market: Drivers

Figure 5: Global Mobile Blood Glucose Meter Market: Challenges

Figure 6: Global Mobile Blood Glucose Meter Market: Trends

Figure 7: Global Mobile Blood Glucose Meter Market: Opportunity

Figure 8: Global Mobile Blood Glucose Meter Market: Restraint

Figure 9: Global Mobile Blood Glucose Meter Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Mobile Blood Glucose Meter Market Value (USD Million) By Region

Figure 15: Global Mobile Blood Glucose Meter Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Mobile Blood Glucose Meter Market Value (USD Million) By Region

Figure 23: Global Mobile Blood Glucose Meter Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Mobile Blood Glucose Meter Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Mobile Blood Glucose Meter Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Mobile Blood Glucose Meter Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Mobile Blood Glucose Meter Market Value (USD Million) By Region

Table 10: Global Mobile Blood Glucose Meter Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Mobile Blood Glucose Meter Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Mobile Blood Glucose Meter Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Mobile Blood Glucose Meter Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: LabStyle Innovations Basic Information And Sales Area

Table 31: LabStyle Innovations. Products Portfolio

Table 32: Roche Diabetes Care Basic Information And Sales Area

Table 33: Roche Diabetes Care. Products Portfolio

Table 34: ACON Basic Information And Sales Area

Table 35: ACON. Products Portfolio

Table 36: Sinocare Basic Information And Sales Area

Table 37: Sinocare. Products Portfolio

Table 38: I-SENS Basic Information And Sales Area

Table 39: I-SENS. Products Portfolio

Table 40: Segments Basic Information And Sales Area

Table 41: Segments. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Mobile Blood Glucose Meter Market Value (USD Million) By Region

Table 47: Global Mobile Blood Glucose Meter Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Mobile Blood Glucose Meter Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.85 billion
Revenue forecast in 2033	4.97 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LabStyle Innovations; Roche Diabetes Care; ACON; Sinocare; I-SENS; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options